StonvexLoading…
StonvexStonvexStonvexCore line items from OPAD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $567.81M | $918.82M | $1.31B | $3.95B |
Operating Income | $-33.39M | $-46.04M | $-104.41M | $-127.32M |
Net Income | $-46.38M | $-62.16M | $-117.22M | $-148.61M |
EPS (Diluted) | $-1.50 | $-2.27 | $-4.44 | $-9.09 |
Total Assets | $154.77M | $313.05M | $379.69M | $825.07M |
Total Liabilities | $116.55M | $265.40M | $277.92M | $703.19M |
Cash & Equivalents | $26.54M | $43.02M | $75.97M | $97.24M |
Free Cash Flow OCF − CapEx | $65.73M | $15.43M | $261.50M | $304.33M |
Shares Outstanding | 30.99M | 27.41M | 26.39M | 16.34M |